use of semaglutide for weight loss FDA Approves Oral Semaglutide: First GLP-1 Pill Personalized Weight Management Support in

Biochemistry 50 , 1076410770 (2011)

In addition, assessment of the projected glycemic effectiveness associated with oral semaglutide based on trial data indicated that 62% of patients would achieve an HbA1c level below 7%, and 43% would achieve their optimal individualized HbA1c target

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are rapidly changing how millions manage weight, signaling a new era for health and fitness professionals

Tirzepatide : Mounjaro (diabetes) and Zepbound (weight management)

Dorsch et al., 2011

Strong Evidence but More Research Needed The results were published in The Lancet Psychiatry , a leading journal in the field